Skip to main content
Fig. 3 | Molecular Autism

Fig. 3

From: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Fig. 3

Change in mean (95% CI) total SRS-2 raw scores from baseline using sex- and fever response-matched pairs. Scores between sulforaphane (SF) and placebo (PL) groups did not differ significantly. Both groups’ scores improved during the open label phase after 15 weeks (shaded box). Note: 95% CI not shown for 36 weeks due to small sample size; see Additional file 1: Table S5 for mean (SD)

Back to article page

Molecular Autism

ISSN: 2040-2392